New Aptar Mumbai Site to Increase Manufacturing Capabilities.

Manufacturing capabilities at Aptar Mumbai, which began in 2012 with the assembly and supply of metered dose valves and pumps, have now been expanded to offer more innovative product solutions and ensure increased manufacturing capacity to pharma customers in South East Asia.

Assembly operations and product delivery to customers have already begun at Aptar Mumbai’s new 7,000 m2 state-of-the art site, which has also received ISO 15378 certification.

This expansion, which began in early 2022, is in line with Aptar’s localization strategy, and is a direct response by Aptar Pharma to growing customer demand in the region.

“Our Aptar Pharma business in India has shown robust growth in recent years, and today marks yet another milestone in our investment in the South East Asia region,” commented Gael Touya, President, Aptar Pharma. “Over the past 11 years, Aptar Mumbai has continuously supplied safe, high-quality products that meet even the highest of regulatory requirements. This new facility is a key step in serving the needs of our customers in the region, which will ultimately benefit patients.”

Sanjay Kapote, President, India & Head, Pharma – SEA, said, “This new site in Mumbai provides a larger space, not only for the expansion of our well-established assembly operations, but also to fuel further localization and support our vision of bringing in other Aptar Pharma technologies suitable for the Asian market.”

Aptar Pharma Prescription President, Alex Theodorakis, commented on more than a decade of success for Aptar Pharma in India, which he described as both a key pillar in the pharma ecosystem and a new chapter of growth in the region.

In her virtual address, Xiangwei Gong, President, Aptar Asia, wholeheartedly congratulated the global and local Aptar Pharma teams for their tireless efforts that contributed to the completion of the Mumbai facility in just under two years. She also noted how this new site will enhance local capabilities, allowing Aptar Pharma to be closer to its customers and to serve them with speed and agility. She also spoke of the growth opportunities for local talent and expected business growth that the new Aptar Mumbai facility will provide.

Ciara Jackson

Senior Marketing Manager, Aptar Pharma https://www.aptar.com/pharmaceutical

For media & press release connect with RV @ +917710030004

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.